Plain-English translation of NCT06033014 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers have developed a computer algorithm called PMHeartIHD that predicts how patients with ischemic heart disease (a condition where blood flow to the heart is blocked) will fare over the next year. This study tests whether giving doctors access to this prediction helps them make better treatment decisions and keep patients healthier. Half of participants will have their predictions shared with their doctor, and half will receive standard care without the algorithm's predictions — this comparison helps researchers understand if the tool actually improves outcomes.
Many heart disease patients need hospital care, but doctors don't always have clear guidance about which patients are at highest risk of dying or needing readmission. This new tool aims to fill that gap by giving doctors a data-driven prediction so they can tailor treatment more carefully and prevent complications.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be hospitalized and receive standard heart disease treatment. Researchers will use the PMHeartIHD algorithm to calculate your one-year survival risk. Depending on which group you're randomly assigned to, your doctor either will or won't see this prediction — but your medical care will continue as usual. The study follows your health for one year to compare outcomes between the two groups.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Denmark